Does Coenzyme Q10 Supplementation Improve Testicular Function and Spermatogenesis in Male Mice with Chronic Kidney Disease?
Chih-Wei TsaoYu-Juei HsuXiang-Ting TsengTing-Chia ChangChang-Huei TsaoChin-Yu LiuPublished in: Biology (2021)
The aim of the study was to examine the potential effects of coenzyme Q10 (CoQ10) on reproductive function in a chronic kidney disease (CKD) mouse model. Nine-week-old mice were randomly assigned to two groups: sham surgery (n = 18) and CKD surgery (n = 18). After surgery, the study groups received CoQ10 (10 mg/kg body weight dissolved in corn oil by oral gavage) or corn oil as a vehicle daily for 8 weeks. The groups that underwent 5/6 nephrectomy developed significant elevations of serum BUN and creatinine levels. The CoQ10 treatment significantly increased the serum and testicular CoQ10 levels and alleviated the poor semen quality from incomplete spermatogenesis. The testosterone concentration, in addition to the protein expression of enzymes related to testosterone biosynthesis, was also elevated, and the CKD-induced decrease in antioxidant activity in the testes was significantly ameliorated. The results suggest that CoQ10 could act against CKD-induced testicular dysfunction through improvements in the sperm function, testicular morphology, testosterone levels and related biosynthesis pathways, in addition to antioxidant activity.
Keyphrases
- chronic kidney disease
- end stage renal disease
- body weight
- germ cell
- replacement therapy
- mouse model
- minimally invasive
- diabetic rats
- coronary artery bypass
- clinical trial
- drug induced
- oxidative stress
- physical activity
- randomized controlled trial
- surgical site infection
- atrial fibrillation
- adipose tissue
- fatty acid
- quality improvement
- peritoneal dialysis
- uric acid
- human health
- preterm birth
- study protocol
- combination therapy